Last updated on February 2018

Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease

Brief description of study

The purpose of this study is to evaluate whether oral finerenone (study drug), in addition to standard daily therapy, is effective and safe in treating patients with type 2 diabetes mellitus and diabetic kidney disease, when compared to a placebo.

Clinical Study Identifier: NCT02545049

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Myrtle Beach, SC United States
  Connect »